Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 795 participants.

Also called NCT02548611

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 795 participants (enrolled count) (from the registry)
Sponsor
  • LMU Klinikum Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02548611
Other papers using this trial's data
  • Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention: The SASSICAIA Trial Circulation. Cardiovascular interventions, 2020-06 DOI, PubMed 32527192

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Hungary (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02548611. Randomized; single masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2018-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
Acronym
SASSICAIA
Condition
Angina Pectoris
Intervention (Drug)
Prasugrel
Intervention (Drug)
Clopidogrel
Lead sponsor
LMU Klinikum (class: other)

Record details

Record id
cardio:ct-nct02548611
Content hash
0623644e20e9969b8079f5c72757460d30efdd11fc3a9b568aef1e35ad386803